chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Prior to receiving the shot on 11/5 and the days leading up to I was healthy and feeling perfectly fine. Around 1:00 I began to notice a funny painful feeling in my left arm, so I walked over to one of my pharmacist to be informed my arm was swollen. That same day as I laid down for bed my body felt off.  However, on 11/6 I woke up for work but I could not make my body get up because it felt really week. Once I was able to get up I began to walk towards the bathroom and I became really dizzy so I immediately laid down and called into to work. During that same day I began experience muscle pains, and body sweats. On 11/7 as I woke up for work I woke up with a really bad headache, so I decided to just call into work again. I went back to sleep and I began to experience chills and fever, but not once did I feel sick it was more like I was just having weird symptoms. On 11/8 I woke up and I was still dealing with my same symptoms, but I was managing to move around okay. It was about 5:30pm that night and my voice just left. I could barely get a word out clear enough or loud enough to be understood. Thats when I googled and read up on my symptoms and they were all listed under a severe reaction to the shot. On 11/9 I went to the ER and they told me I had the flu as well as pneumonia which I never had before. And last year after receiving the shot it caused me to be sick as well
After 2 minutes taking the vaccine, I had difficult breathing, fast heartbeat, dizziness and weakness. I called the pharmacist and asked for my blood pressure to be checked, the machine was without battery. By the time the machine was working, my blood pressure was higher than my normal, I think 10/14. I asked for water and got better after 5 min. I ended up staying there for 30 minutes to be safe.
Headache, Sedation, Myalgia, Arthralgia, Pain at injection site and axilla Narrative:
Fully vaccinated on 04/13/2021, Hospitalization on 11/29/2021 for COVID positive. history of GERD, Systemic Lupus  Erythematosus, Coronary artery disease
This is a spontaneous report received from contactable reporter(s) (Other HCP and consumer or other non-HCP). A female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "recovered" (2021), described as "Patient reported in an informal setting that she got the vaccine a month ago and felt bad the next day". It was unknown if therapeutic measures were taken as a result of feeling abnormal. Response: I became aware of the adverse events on 04Mar2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
throat swelling immediately following injection; received epi.  next morning woke up with cough, fatigue, muscle aches
neuropathy; shingles; Incomplete course of vaccination; This case was reported by a consumer via interactive digital media and described the occurrence of neuropathy in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and did not receive the 2nd dose of Shingles vaccine. On an unknown date, between 1 and 2 years after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced neuropathy (serious criteria GSK medically significant), shingles and incomplete course of vaccination. On an unknown date, the outcome of the neuropathy and shingles were not recovered/not resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the neuropathy and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 02-June-2022 Reporter's Comments: This case was reported by the patient via interactive digital media. The patient got the 1st Shingles vaccine about a year and a half before reporting, the patient did not get the 2nd dose. The patient got Shingles 2 months before reporting and was still not well. The patient had no blisters, had neuropathy. The patient wanted to know if he/she could get the second dose or should start over. Additional Supportive Information: Till the time of reporting, the patient did not get the 2nd dose of Shingles vaccine, which led to incomplete course of vaccination. The follow-up would not be possible as no contact details were available.
Received vaccine RD 10/12/09 - Developed redness, swelling, itching, in area 10/14/09 - Seen in Empl. Health 10/15/09 - Sent to clinic - localized cellulitis (R) arm - Placed on LEVAQUIN and BENADRYL. In Resp. Sx noted - Taking meds. out of work 4 days stating 10/15/09.
11 am vaccine given, by 5 pm there was a huge knot/ swollen lymph node with a red circle around it.   Iced area the swollen area, and Tylenol
Moderns COVID-19 Vaccine Sat at about 8pm started to have arm pain in the arm vaccinated. Throughout the night muscle, aches, headaches, fever, chills and fatigue started. Treated with Tylenol. Sunday moring fever, headache and chills were gone. Noon on Sunday, chillw and fever came back. 4pm checked temp and it was 103 degrees. Took Tylenol.
20 minutes after the shot my throat became itchy. I was given pepcid and benadryl.  I felt real foggy for the first 30 minutes after the shot. 15 minutes after benadryl I felt better. One week later I started itching especially my head. I did not have anything on my skin but I would just itching for no reason.  Also, I started experiencing heart palpations more than usual. I have some palpations at times but this was more than usual. I have experienced these reactions since then. That was Jan. 29 and today is Feb. 2. Today the itching is better but continue to have heart palpation.  I am concerned about taking the 2nd dose of the COVID vaccine Feb. 12. I would like for someone to contact me by phone if any way possible.
This case was reported by a pharmacist and described the occurrence of swelling of tongue in an adult subject of unspecified gender who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. On an unspecified date in October 2006, on or before 26 October 2006, the subject received unspecified dose of Fluarix. On an unspecified date in October 2006, less than one month after vaccination with Fluarix, the subject experienced swelling of tongue and injection site irritation. The subject was seen at a physician's office. The subject was treated with oral diphenhydramine hydrochloride (Benadryl). At the time of initial reporting, 26 October 2006, the tongue swelling had resolved.
102.4 F fever,  fatigue, body aches, and accelerated heart rate . Only lasted 24 hrs. but it was rough.
Bell?s Palsy left side face/ swelling in head/ brain Tele. Dr instructions antiviral if continues and visit in person
3 cc administered - drug error - 6 dose injection. Arm painful, red @ injection site.
Patient received FLUZONE HD on 10/24/10. Later that evening reported violent shaking but no chills. Upon ER visit patient described high blood pressure and blood sugar that same night. Patient was not admitted, but reports flu-like symptoms at home.
dose administered after vial appeared to have frost-like ring at the bottom after drawing up 5; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (dose administered after vial appeared to have frost-like ring at the bottom after drawing up 5) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (dose administered after vial appeared to have frost-like ring at the bottom after drawing up 5). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (dose administered after vial appeared to have frost-like ring at the bottom after drawing up 5) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-095302, US-MODERNATX, INC.-MOD-2021-095367, US-MODERNATX, INC.-MOD-2021-095633 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095302: US-MODERNATX, INC.-MOD-2021-095367: US-MODERNATX, INC.-MOD-2021-095633:
ACHES; FEVER; TIREDNESS; SORENESS AT POINT OF SHOT (10/10); This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced aches, fever, tiredness, and soreness at point of shot (10/10). Laboratory data (dates unspecified) included: Pain scale (NR: not provided) 10/10. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, aches, tiredness and soreness at point of shot (10/10) was not reported. This report was non-serious.
Vial was initially stored in the refrigerator on 13-Jul-2022, administered on 12-Aug-2022 and use by date was 11-Aug-2022; No adverse event; Dose administered after 30 day Use By Date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30 day Use By Date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 13-Jul-2022, administered on 12-Aug-2022 and use by date was 11-Aug-2022) and NO ADVERSE EVENT (No adverse event) in an infant patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9237B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30 day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 13-Jul-2022, administered on 12-Aug-2022 and use by date was 11-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30 day Use By Date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 13-Jul-2022, administered on 12-Aug-2022 and use by date was 11-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30 day Use By Date) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 13-Jul-2022, administered on 12-Aug-2022 and use by date was 11-Aug-2022).    Vaccine was administered on 12-Aug-2022 before 11 AM. Concomitant medication list was not provided. It was reported that the vaccine was pulled from the ultra cold on 13J-uly-2022 but there was no time listed. Use by day was 11-Aug-2022. Based on the count, they counted 13-Jul-2022 as day 1. Number of doses per vials were 4 infants doses. The vial was initially stored in the refrigerator on 13-Jul-2022. The vial had not underwent any temperature excursions Treatment information was not provided. This case belongs to the fourth infant out the 4 infants who received a expired vaccine.   This case was linked to US-MODERNATX, INC.-MOD-2022-628905, US-MODERNATX, INC.-MOD-2022-628903, US-MODERNATX, INC.-MOD-2022-628899 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-628905:Infant patient 3 US-MODERNATX, INC.-MOD-2022-628903:Infant patient 2 US-MODERNATX, INC.-MOD-2022-628899:Infant patient 1
Information has been received from a consumer concerning her 4 year old grand daughter with juvenile arthritis and history of allergic reaction to child hood shots who on 07-DEC-2007 was vaccinated with a dose of Hib conj vaccine (OMPC) (lot # unknown). Concomitant therapy included methotrexate and naproxen. The reporter that after one day of receiving Hib conj vaccine (OMPC) on 09-DEC-2007 her grand daughter developed red streaks on her right arm and the entire arm was swollen. Her right arm was three times bigger than her left arm and was very red and warm. She was prescribed extra strength BENADRYL and an antimicrobial (unspecified). She no longer had a swollen arm and the pain had gone away except at the injection site where she still had a red knot. The knot was the size of a half dollar. No further information was available. The patient was recovering. Additional information has been requested.
a few min p/vax c/o stomach upset, nausea, dizziness, cold forehead, pale;vital signs nl (t36.2, HR 60, BP 90/50 sit-80/40 stand, rr20);no urticaria or resp distress;skin warm & dry;sl clammy;
she started developing severe soreness in her left shoulder ( consumer referred to it as "Sirva") where she received the injection.; This spontaneous report as received from a 72-year-old female patient concerning herself with high blood pressure, asthma, and drug reactions/allergies to fexofenadine hydrochloride (+) pseudoephedrine hydrochloride (ALLEGRA D), morphine, "NORAVAX", "nutraflurotin", sulfamethoxazole (+) trimethoprim (BACTRIM), and clarithromycin (MACROBID). The consumer  mentioned that she had a similar issue (severe soreness in her shoulder (referred to it as "Sirva") where she received the injection) with her right arm from a flu shot several years ago. Concomitant therapies included losartan potassium (manufacturer unknown), carvedilol, simvastatin (manufacturer unknown), esomeprazole magnesium(NEXIUM), mometasone furoate(NASONEX), and guaifenesin(MUCINEX).  On 20-OCT-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (strength, dose, route, lot number, and expiration date were not provided) in the left arm for prophylaxis.         On same date, she started developing severe soreness in her left shoulder (consumer referred to it as "Sirva") where she received the injection. Consumer stated that it started as a sharp shooting pain in her shoulder and had consisted to the point that she "could not lift groceries out of her car". On 15-DEC-2020 (reported as Tuesday), the patient was planning on seeing her a doctor to discuss this ongoing issue with her left shoulder. There were no laboratories/studies performed.   The outcome of injection site pain was reported as not resolved. The causality between the event and the suspect vaccine was not provided.  The reporter considered this event to be a disabling event.
Two separate episodes of urticaria with normal skin in between. First episode started 10/1/23 resolved by 10/6/23, second episode today 10/27/23. No other cause identified. Today the rash is on my face and chest as well as at the vaccine site but currently starting to spread to my back and stomach. The rash is extremely erythematous and I also have facial swelling. It is pruritic but that improves with antihistamine.
A 12 year old patient was administered the Moderna COVID.19 vaccine as first dose.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 12 year old patient was administered the Moderna COVID.19 vaccine as first dose.) in a 12-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 12 year old patient was administered the Moderna COVID.19 vaccine as first dose.). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 12 year old patient was administered the Moderna COVID.19 vaccine as first dose.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medication were reported.
Information has been received from a registered nurse concerning a 48 years old female patient with no drug reactions/allergies and gastroesophageal reflux disease (GERD) who on 04-OCT-2012, was vaccinated with a dose of PNEUMOVAX23 0.5 ml IM, at right arm (lot #672366/1723AA, Exp: 27-JUL-2013). No other co-suspects were reported. Concomitant medications included: unspecified flu vaccine (manufacturer Sanofi) given on the same day (left arm), and omeprazole. On 04-OCT-2012, the patient experienced dizziness and nausea, and soreness, redness and swelling of her right arm at the injection site after receiving PNEUMOVAX23. The patient made phone call to office and was advised to use ice packs and to elevate her arm. The outcome of the events was reported as recovered/resolved (in 2012 exact date unspecified). No diagnostic laboratory studies were performed. The relatedness for the events was unknown for PNEUMOVAX23. This is one of several reports received from the same source (related MARRS # 1211USA005870). Additional information has been requested.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of live ZOSTAVAX (dose, route and lot # not reported). No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient developed shingles after receiving live ZOSTAVAX. The patient sought unspecified medical attention. The outcome of shingles was unknown. The relatedness for shingles was unknown for live ZOSTAVAX. Additional information has been requested.
suddenly without any symptoms the patient was squeezing quarter sized clots from bladder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03May2021 13:15 (Lot number: ew0173) at the age of 69 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The following information was reported: URINARY BLADDER HAEMORRHAGE (medically significant) with onset 16May2021, outcome "unknown", described as "suddenly without any symptoms the patient was squeezing quarter sized clots from bladder". The event "suddenly without any symptoms the patient was squeezing quarter sized clots from bladder" was evaluated at the emergency room visit. It was unknown if therapeutic measures were taken as a result of urinary bladder haemorrhage.  No follow-up attempts are possible. No further information is expected.
Patient received Pfizer COVID-19 vaccine on 7/1/2021. After vaccine was administered it was found that patient had previously received Johnson and Johnson COVID-19 Vaccine on 3/11/2021.
Received 2nd Hep A and a Menactra immunization on the morning of 7/27/05.  Mother states about 4AM on 7/28 had vomiting without nauseam, sore throat, fever of 101, pale, dizzy, headache, and "fast heart beat".  Symptoms relieved with Tylenol.  Morning of 7/29 feeling much better and went to work.   Discussed with mother that symptoms could be related to something other than the vaccine but that we would report her concerns.
Fluid filled blister appeared at injection site approximately 28 hours after injection along with red rash and itching.
I have hives/rash over my face, arms, trunk, legs, ankles and bottom of my feet.  I had extreme fatigue the evening after the vaccine.
Head cold; Diarrhea; developed a kind of allergies like a scratchy throat; Congested; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL9262), via an unspecified route of administration on 25Jan2021 (at the age of 72-years-old) as a single dose for COVID-19 immunization. The patient's medical history included 'thyroid' from an unspecified date and unknown if ongoing. Concomitant medications were not reported. On an unknown date, reported as all of the sudden, the patient experienced a kind of allergy like a scratchy throat and then I was congested, a bad head cold (started last week) and from last night I started to have diarrhea. The clinical outcome of head cold, diarrhea, scratchy throat and congested was unknown.
Immunizations on 9/5/03; stiffness and swelling on right thigh on 9/6/03. To Dr. for f/u 9/8/03. Area warm, not tender, mild erythema 7 x 4.5cm. Started on Keflex 250mg/5ml, dose 5.5ml PO every 8 hours (TID) for 10 days.
PT. DOESNT HAVE ANY SYMPTOMS  OR ISSUE WHEN LEAVING OFFICE. DID INFORM GUARDIAN OF INFORMATION IN REGARD TO SHOT.
Redness soreness malaise feeling pain at injection site.(reading the information all normal side effects).
c/o fever 103.4, chills, sweating, weakness, sl dizziness, nausea w/o vomiting, pain in hands & legs p/vax;denies stiff neck;